Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
68,958,635
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
71,278,859
-
Shares change
-
+10,428,389
-
Total reported value, excl. options
-
$415,382,388
-
Value change
-
+$48,509,843
-
Put/Call ratio
-
0.55%
-
Number of buys
-
81
-
Number of sells
-
-48
-
Price
-
$5.83
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q4 2024
171 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock as of Q4 2024.
Olema Pharmaceuticals, Inc. - Common Stock (OLMA) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71,278,859 shares
.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (7,470,214 shares), Paradigm Biocapital Advisors LP (7,304,970 shares), BVF INC/IL (5,715,893 shares), BlackRock, Inc. (3,789,832 shares), Point72 Asset Management, L.P. (3,670,826 shares), Deep Track Capital, LP (3,442,833 shares), Logos Global Management LP (3,208,875 shares), MPM BIOIMPACT LLC (2,912,550 shares), VANGUARD GROUP INC (2,685,009 shares), and LIGHTSPEED MANAGEMENT COMPANY, L.L.C. (1,930,894 shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.